Correlation of Increased Soluble Tumor Necrosis Factor Receptor 1 with Mortality and Dependence on Treatment in Non-Small-Cell Lung Cancer Patients: A Longitudinal Cohort Study
Open Access
Abstract
Background: Tumor necrosis factor (TNF) is a multipotent cytokine involved in inflammation and anti-tumor activity. TNF- exerts its function upon binding to TNF-receptor 1 (TNF-R1) and TNF-receptor 2 (TNF-R2). This study investigates the relationship of soluble (s) TNF-R1 levels in non-small-cell lung cancer (NSCLC) patients with treatment and overall survival. Methods: In total, 134 NSCLC patients treated at the Medical Faculty of Martin Luther University Halle-Wittenberg between 2017 and 2019 were included in this study. Serum levels of sTNF-R1 were measured via ELISA at baseline and during and after treatment. A linear mixed-effects model was used to assess sTNF-R1 changes over time. Linear regression was applied to investigate the association between clinical characteristics and changes in sTNF-R1. Cox regression models were used to estimate associations with overall mortality. Results: The estimated average sTNFR-1 at baseline was 2091.71 pg/mL, with a change of 6.19 pg/mL per day. Cox models revealed that the individual change in sTNF-R1 was more strongly associated with mortality than its baseline value, especially after adjusting for covariates. Conclusions: This study provides evidence that the individual change in sTNF-R1 levels during and after treatment were associated with the risk of mortality, suggesting the use of the sTNF-R1 trajectory as a prognostic marker.
Keywords
This publication has 35 references indexed in Scilit:
- Radiation as an immunological adjuvant: current evidence on dose and fractionationFrontiers in Oncology, 2012
- Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumoursArchives of Medical Science, 2012
- The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- Cardiovascular diseases, risk factors and short-term heart rate variability in an elderly general population: the CARLA study 2002–2006European Journal of Epidemiology, 2009
- Tumor necrosis factor (TNF) biology and cell deathFrontiers in Bioscience-Landmark, 2008
- Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancerCancer, 2007
- The paradox of pro-inflammatory cytokines in cancerCancer and Metastasis Reviews, 2006
- Signalling pathways of the TNF superfamily: a double-edged swordNature Reviews Immunology, 2003
- Tumor necrosis factor signalingCell Death & Differentiation, 2003
- Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinomaCancer, 1998